Biora Therapeutics, Inc.

BIOR · OTC
Analyze with AI
9/30/2024
6/30/2024
3/31/2024
12/31/2023
Operating Activities
Net Income$91$6-$4-$16
Dep. & Amort.-$0$0$0$0
Deferred Tax$0$0$0-$3
Stock-Based Comp.-$0$2$2$2
Change in WC$33$3$2-$1
Other Non-Cash-$132-$22-$12$4
Operating Cash Flow$32-$11-$12-$14
Investing Activities
PP&E Inv.$0-$0-$0-$0
Net Acquisitions$0$0$0-$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$3$0$3$0
Other Inv. Act.-$3$0$0$3
Investing Cash Flow-$0-$0$3$2
Financing Activities
Debt Repay.$8$0$3$10
Stock Issued$0$3$3$5
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$2$2-$0-$2
Financing Cash Flow$7$6$5$14
Forex Effect$0$0$0$0
Net Chg. in Cash-$2-$5-$4$3
Supplemental Information
Beg. Cash$5$11$15$13
End Cash$3$5$11$15
Free Cash Flow$32-$11-$13-$14
Biora Therapeutics, Inc. (BIOR) Financial Statements & Key Stats | AlphaPilot